Gentium shareholders

Shareholders sue Gentium board, Jazz Pharmaceuticals to halt deal

Gentium investors sued the company's board and Jazz Pharmaceuticals in an attempt to stop the acquisition of Gentium, claiming that the tender offer was flawed, Bloomberg reported.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics